AspertecTM – Developing a Better Aspirin Using Our PLxGuardTM Delivery System

Learn about Aspertec 325 mgLearn About the PLxGuard Delivery System

About PLx

We are a late-stage specialty pharmaceutical company initially focused on using our clinically validated and patent-protected PLxGuard delivery system to develop Aspertec, a more effective aspirin product than the current standard of care for cardiovascular disease prevention which is enteric coated aspirin.

Learn More

PLxGuard Delivery System

Our PLxGuard Delivery System works by releasing active pharmaceutical ingredients into the duodenum, the first part of the small intestine immediately below the stomach, rather than in the stomach itself. We believe this improves the absorption of many drugs currently on the market or in development, and reduces acute gastrointestinal (GI) side effects — including erosions, ulcers, and bleeding — associated with aspirin and ibuprofen, and potentially other drugs.

Learn More

Stock Quote

PLXP (Common Stock)

$6.59
+0 (+0%)
Exchange
NASDAQ CM
Volume
6,849
Today's Open
$6.59
Previous Close
$6.35
09/22/17 15:46:00 EDT

Learn More